BSECompany Update16h ago · 28 Oct 2026, 03:49 pm

Please find enclosed Intimation for Investor Call scheduled to be held on 4th November, 2026.

Alembic Pharmaceuticals Ltd · 533573

✦ AI SummaryResults

Alembic Pharmaceuticals Ltd has scheduled a post-results conference call for analysts and institutional investors on November 4, 2026, to discuss its Q2 FY27 unaudited financial results.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

e73fee37-6319-4908-80ba-54f268e6c628.pdf

pdf

Download →
View document text
28th October, 2026 To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex, Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 533573 NSE Symbol: APLLTD Dear Sir/Madam, Sub: Schedule of Post Results Conference Call The exchange is hereby informed that the Company will hold Post Results Conference Call only for analysts / institutional investors on Wednesday, 4th November, 2026 as per the enclosed details. We request you to kindly take the same on record. Thanking you, Yours faithfully, For Alembic Pharmaceuticals Limited Chirag K. Shukla Company Secretary Encl.: A/a ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123 28th October, 2026 CONFERENCE CALL We are organizing a conference call with our Senior Management Team Members to discuss the Company’s Q2 FY27 Unaudited Financial Results on Wednesday, 4th November, 2026 at 4:00 P.M. IST. Details of the conference call are as under: Time: 4:00 P.M. IST on Wednesday, 4th November, 2026 Option 1: To enable participants to connect to the conference call without having to wait for an operator, please register at the below mentioned link: Click →: Diamond Pass Registration You will receive dial in numbers, passcode and a pin for the concall on the registered email address provided by you. Kindly dial into the call on the conference call date and use the passcode & pin to connect to the call. Option 2: Conference dial-in: Universal Access Number +91 22 6280 1411 +91 22 7115 8312 India Toll Free Number 1 800 120 1221 International Toll Free USA 1866 746 2133 Number UK 080 810 11573 Singapore 800 101 2045 Hong Kong 800 96 4448 For further information contact: Isha Lamba Phone: +91 22-66951652 Email: isha.lamba@alembic.co.in ALEMBIC PHARMACEUTICALS LIMITED REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229 Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123